Innovation is a key word throughout the pharmaceutical industry and the healthcare community and its pursuit is a business imperative for Pharma.
Pharma urgently needs to produce innovative new therapies if it is to overcome its critical, long-term challenge, ie the revenue gap produced by the industry’s failure to develop sufficient, new, patent-protected medical therapies to offset the revenues lost as existing products lose their patent protection.
Our members are committed to encouraging expert, external, systems suppliers to provide hosted, secure, shared resources to support R&D processes in the precompetitive domains of the life science R&D industries
Bioceutical Technology transfer is going to play a crucial role in success. Companies who thrive are likely to be those that place bold bets and wait patiently for results.